{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:38:26Z","timestamp":1787499506324,"version":"build-2736575974"},"reference-count":133,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.semarthrit.2021.09.004","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T10:54:30Z","timestamp":1631789670000},"page":"1205-1217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy"],"prefix":"10.1016","volume":"51","author":[{"given":"Hanh","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawser","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weike","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2021.09.004_bib0001","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12026-014-8572-6","article-title":"Predictors of maternal and fetal complications in SLE patients: a prospective study","volume":"60","author":"Borella","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0002","doi-asserted-by":"crossref","DOI":"10.1002\/art.21663","article-title":"Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis","author":"Chakravarty","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajog.2008.03.012","article-title":"A national study of the complications of lupus in pregnancy","volume":"199","author":"Clowse","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0004","first-page":"1235","article-title":"Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: Disease activity matters","volume":"57","author":"Zbinden","year":"2018","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0005","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0006","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part II: Analgesics and other drugs used in rheumatology practice","author":"Flint","year":"2016","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0007","article-title":"BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: Standard and biologic disease modifying anti-rheumatic drugs and corticosteroids","author":"Flint","year":"2016","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0008","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","author":"Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0010","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1177\/2168479013497597","article-title":"Medicines in Pregnancy-Women and Children First? Time for a Coalition to Address a Substantial Patient Need","volume":"47","author":"Dewulf","year":"2013","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-017-1269-1","article-title":"Risk factors for flare and treatment of disease flares during pregnancy in rheumatoid arthritis and axial spondyloarthritis patients","volume":"19","author":"van den Brandt","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0012","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.3748\/wjg.v20.i23.7123","article-title":"Inflammatory bowel diseases and human reproduction: A comprehensive evidence-based review","volume":"20","author":"Palomba","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0013","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.semarthrit.2018.07.011","article-title":"Safety of anti-rheumatic drugs in men trying to conceive: A systematic review and analysis of published evidence","volume":"48","author":"Mouyis","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0014","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/bmj.1.5390.1090","article-title":"Preliminary Communications \/Observations on Progeny of Thalidomidetreated Male Rabbits","author":"Lutwak-Mann","year":"1964","journal-title":"Br Med J"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0015","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/2141018a0","article-title":"Thalidomide in rabbit semen","volume":"214","author":"Lutwak-Mann","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0016","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7326\/0003-4819-126-4-199702150-00005","article-title":"Use of testosterone to prevent cyclophosphamide-induced azoospermia","volume":"126","author":"Masala","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1439-0272.1984.tb00258.x","article-title":"Abnormal Semen Quality and Low Serum Testosterone in Men with Inflammatory Bowel Disease Treated for a Long Time with Sulfasalazine","volume":"16","author":"RAGNI","year":"1984","journal-title":"Andrologia"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0018","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/bdrb.20031","article-title":"The transport of chemicals in semen","volume":"74","author":"Klemmt","year":"2005","journal-title":"Birth Defects Res Part B - Dev Reprod Toxicol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0019","doi-asserted-by":"crossref","first-page":"e380","DOI":"10.1016\/S2214-109X(18)30029-9","article-title":"Global, regional, and subregional trends in unintended pregnancy and its outcomes from 1990 to 2014: estimates from a Bayesian hierarchical model","volume":"6","author":"Bearak","year":"2018","journal-title":"Lancet Glob Heal"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0020","first-page":"50931","article-title":"The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration","volume":"6","author":"Alessandro","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0021","first-page":"488","article-title":"Grading quality of evidence and strength of recommendations","volume":"325","author":"Atkins","year":"2002","journal-title":"Bmj"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.lpm.2014.05.021","article-title":"Inefficacy of plasma exchanges associated to rituximab in refractory obstetrical antiphospholipid syndrome","volume":"44","author":"Abisror","year":"2015","journal-title":"Press Medicale"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0023","first-page":"1047","article-title":"Low level of Rituximab in human breast milk in a patient treated during lactation","volume":"56","author":"Bragnes","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5414\/CN109584","article-title":"Successful pregnancy in a patient with pulmonary renal syndrome double-positive for anti-GBM antibodies and p-ANCA","volume":"91","author":"Sprenger-M\u00e4hr","year":"2019","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0025","first-page":"6072","article-title":"Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2 R Antibodies: A Case","volume":"118","author":"Al-Rabadi","year":"2016","journal-title":"Report"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaad.2009.05.015","article-title":"Apparent safe use of single dose rituximab for recalcitrant atopic dermatitis in the first trimester of a twin pregnancy","volume":"63","author":"Ponte","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0027","first-page":"405","article-title":"Modified neonatal B-cell repertoire as a consequence of rituximab administration to a pregnant woman","volume":"52","author":"Mart\u00ednez-Mart\u00ednez","year":"2013","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0028","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s11845-008-0265-5","article-title":"Successful pregnancy after rituximab in a women with recurrent in vitro fertilisation failures and anti-phospholipid antibody positive","volume":"178","author":"Ng","year":"2009","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0029","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S1701-2163(16)34741-7","article-title":"Rituximab for Management of Refractory Pregnancy-Associated Immune Thrombocytopenic Purpura","volume":"32","author":"Gall","year":"2010","journal-title":"J Obstet Gynaecol Canada"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/0961203312463621","article-title":"Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus","volume":"21","author":"Alkaabi","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0031","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/rheumatology\/keq403","article-title":"Safety of rituximab therapy during twins\u2019 pregnancy","volume":"50","author":"Ton","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0032","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/1352458509106512","article-title":"Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab","volume":"15","author":"Pellkofer","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0033","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10067-013-2241-3","article-title":"Pre-conceptional exposure to rituximab: Comment on the article by Ojeda-Uribe et al","volume":"32","author":"Gualtierotti","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0034","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12882-018-0949-7","article-title":"Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: A case report","volume":"19","author":"Harris","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0035","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1177\/1352458513498125","article-title":"Neuromyelitis optica and pregnancy during therapeutic B cell depletion: Infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartum","volume":"19","author":"Ringelstein","year":"2013","journal-title":"Mult Scler J"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0036","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jneuroim.2018.10.008","article-title":"Confusional state in a pregnant woman: A case of NMDA receptor encephalitis during pregnancy","volume":"325","author":"Grewal","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0037","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.msard.2019.101442","article-title":"Initiation of rituximab therapy for new onset neuromyelitis optica spectrum disorder during pregnancy","volume":"37","author":"Munger","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1753495X18813739","article-title":"Rituximab for the maintenance of minimal change nephropathy \u2013 A report of two pregnancies","volume":"13","author":"Holden","year":"2020","journal-title":"Obstet Med"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0039","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/AOG.0000000000003699","article-title":"Multidrug Therapy for Refractory Immune Thrombocytopenia in Pregnancy","volume":"135","author":"Chon","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0040","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/practneurol-2018-002168","article-title":"Difficult case: Rituximab in anti-SRP antibody myositis in pregnancy","volume":"19","author":"Mehta","year":"2019","journal-title":"Pract Neurol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0041","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1212\/NXI.0000000000000542","article-title":"Rituximab during pregnancy in neuromyelitis optica: A case report","volume":"6","author":"Miranda-Acun\u00e3","year":"2019","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0042","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/1471-0528.14856","article-title":"Re: Severe Primary Autoimmune Thrombocytopenia (ITP) in Pregnancy: a national cohort study Primary immune thrombocytopenia management during pregnancy. A French study","volume":"125","author":"Comont","year":"2018","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0043","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1111\/jdv.13962","article-title":"Pemphigoid gestationis: a successful preventive treatment by rituximab","volume":"31","author":"Tourte","year":"2017","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0044","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1753495X18778489","article-title":"Rituximab \u2013 A novel therapy for severe ITP in pregnancy: A case report","volume":"12","author":"Donohoe","year":"2019","journal-title":"Obstet Med"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1753495X18780853","article-title":"A case of ANCA-associated vasculitis presenting de novo in pregnancy, successfully treated with rituximab","volume":"13","author":"Pefanis","year":"2020","journal-title":"Obstet Med"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2008\/271363","article-title":"Rituximab Administration in Third Trimester of Pregnancy Suppresses Neonatal B-Cell Development","volume":"2008","author":"Klink","year":"2008","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0047","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.jp.7211481","article-title":"Administration of rituximab during the first trimester of pregnancy without consequences for the newborn","volume":"26","author":"Ojeda-Uribe","year":"2006","journal-title":"J Perinatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0048","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/imj.13405","article-title":"A case of de novo diagnosis antineutrophil cytoplasmic antibodynegative pauci-immune necrotising glomerulonephritis in pregnancy","volume":"47","author":"Conduit","year":"2017","journal-title":"Intern Med J"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0049","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/01.mbc.0000240918.65306.20","article-title":"Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura","volume":"17","author":"Scully","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0050","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00296-010-1755-0","article-title":"Long-term efficacy of anti-CD20 antibodies in refractory lupus nephritis","volume":"32","author":"Arce-Salinas","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0051","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10067-012-2156-4","article-title":"Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases","volume":"32","author":"Ojeda-Uribe","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0052","first-page":"279","article-title":"Fetal outcomes after rituximab exposure in women with autoimmune vasculitis","volume":"72","author":"Pendergraft","year":"1992","journal-title":"Autoimmune Dis II"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0053","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/rheumatology\/ken168","article-title":"Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs","volume":"47","author":"Ostensen","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0054","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2013.03.001","article-title":"B-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseases","volume":"43","author":"Sangle","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0055","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1111\/jdv.14119","article-title":"Pregnancy outcome after rituximab treatment before conception in patients affected by severe pemphigus vulgaris\/superficialis","volume":"31","author":"Vassallo","year":"2017","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0056","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jns.2017.02.009","article-title":"10-year-outcomes after rituximab for myasthenia gravis: Efficacy, safety, costs of inhospital care, and impact on childbearing potential","volume":"375","author":"Stieglbauer","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0057","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/09546634.2016.1255302","article-title":"Rituximab treatment of pemphigus in women of childbearing age: experience with two patients","volume":"28","author":"Lake","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0058","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000668","article-title":"Pregnancy outcomes in anti-NMDA receptor encephalitis: Case series","volume":"7","author":"Joubert","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0059","first-page":"661","article-title":"Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab","volume":"56","author":"De","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0060","first-page":"688","article-title":"Prospectivelyfollowed pregnancies in patients with inflammatory arthritis taking biological drugs: An Italian multicentre study","volume":"33","author":"Bazzani","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0061","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000734","article-title":"and pregnancy","volume":"7","author":"Smith","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0063","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1007\/s00415-019-09450-6","article-title":"Relapses and obstetric outcomes in women with multiple sclerosis planning pregnancy","volume":"266","author":"Berenguer-Ruiz","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0064","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.msard.2019.01.003","article-title":"Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study","volume":"28","author":"Nguyen","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0065","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/acr.23781","article-title":"Long-Term Safety of Rituximab in Patients With Rheumatoid Arthritis: Results of a Five-Year Observational Study","volume":"71","author":"Winthrop","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0066","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ajh.25632","article-title":"Long-term safety and efficacy of rituximab in 248 adults with immune thrombocytopenia: Results at 5 years from the French prospective registry ITP-ritux","volume":"94","author":"Deshayes","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0067","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfy104.SP189","article-title":"Successful pregnancy in a patient with pulmonary renal syndrome double positive for anti-GBM antibodies and P-ANCA","volume":"33","author":"Sprenger-Maehr","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0068","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1136\/annrheumdis-2018-213004","article-title":"Lymphocyte changes and vaccination response in a child exposed to belimumab during pregnancy","volume":"77","author":"Bitter","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0069","first-page":"1","article-title":"Use of Belimumab throughout 2 Consecutive Pregnancies in a","volume":"40","author":"Kumthekar","year":"2013","journal-title":"Patient with Systemic Lupus Erythematosus"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0070","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.semarthrit.2016.03.005","article-title":"Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report","volume":"45","author":"Emmi","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0071","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2014.05.006","article-title":"Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus-A case report","volume":"44","author":"Danve","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0072","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203319839482","article-title":"Successful conception in a 34-year-old lupus patient following spontaneous pregnancy after autotransplantation of cryopreserved ovarian tissue","volume":"28","author":"Chehab","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0073","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0961203312469259","article-title":"Safety profile of belimumab: Pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus","volume":"22","author":"Wallace","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0074","first-page":"4","article-title":"The Journal of Rheumatology Monoclonal Antibodies","volume":"42","author":"Sandhu","year":"2015","journal-title":"Systemic Lupus Erythematosus, and Pregnancy: Insights from an Open-label Study The Journal of Rheumatology is a monthly international serial edited by Earl D . in rheumatology and related fields"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/03009742.2019.1639821","article-title":"Unexpectedly lower proportion of placental transferred tocilizumab relative to whole immunoglobulin G: a case report","volume":"49","author":"Moriyama","year":"2020","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0076","first-page":"1694","article-title":"Placental transfer of tocilizumab in a patient with rheumatoid arthritis","volume":"58","author":"Tada","year":"2019","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0077","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/1756-185X.13687","article-title":"A successful pregnancy in a patient with Takayasu's arteritis under tocilizumab treatment: A longitudinal case study","volume":"22","author":"Dalkilic","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0078","first-page":"1505","article-title":"Tocilizumab during pregnancy and lactation: Drug levels in maternal serum, cord blood, breast milk and infant serum","volume":"58","author":"Saito","year":"2019","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0079","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3109\/14397595.2016.1140256","article-title":"Tocilizumab and pregnancy: Four cases of pregnancy in young women with rheumatoid arthritis refractory to anti-TNF biologics with exposure to tocilizumab","volume":"26","author":"Kaneko","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0080","first-page":"1499","article-title":"Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: A case study","volume":"57","author":"Saito","year":"2018","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0081","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.reprotox.2016.01.002","article-title":"Pregnancy outcome after tocilizumab therapy in early pregnancy-case series from the German Embryotox Pharmacovigilance Center","volume":"60","author":"Weber-Schoendorfer","year":"2016","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0082","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1007\/s00296-017-3772-8","article-title":"Real-world clinical experience of biological disease modifying anti-rheumatic drugs in Malaysia rheumatoid arthritis patients","volume":"37","author":"Tan","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0083","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2016.05.004","article-title":"Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data","volume":"46","author":"Hoeltzenbein","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0084","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/14397595.2016.1147405","article-title":"Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan","volume":"26","author":"Nakajima","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0085","first-page":"603","article-title":"Pregnancy outcomes in DMARD-exposed patients with juvenile idiopathic arthritis-results from a","volume":"59","author":"Drechsel","year":"2020","journal-title":"JIA biologic registry. Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0086","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13555-018-0232-7","article-title":"Pregnancy After Tubal Sterilization in a Woman Treated with Biologics for Severe Psoriasis","volume":"8","author":"Nardin","year":"2018","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2340\/00015555-3611","article-title":"Successful treatment of recurrent pustular psoriasis of pregnancy with secukinumab: A case report","volume":"100","author":"Liu","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0088","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dth.13040","article-title":"Impetigo herpetiformis responsive to secukinumab","volume":"32","author":"Chhabra","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0089","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/bjd.16901","article-title":"Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database","volume":"179","author":"Warren","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12876-017-0633-6","article-title":"Fetal death in utero and miscarriage in a patient with Crohn's disease under therapy with ustekinumab: Casereport and review of the literature","volume":"17","author":"Venturin","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0091","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/ecco-jcc\/jjx141","article-title":"Ustekinumab drug levels in maternal and cord blood in a woman with Crohn's disease treated until 33 weeks of gestation","volume":"12","author":"Rowan","year":"2018","journal-title":"J Crohn's Colitis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0092","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/jdv.12872","article-title":"Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis","volume":"30","author":"Alsenaid","year":"2016","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0093","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1111\/jdv.13499","article-title":"Successful pregnancy outcome under prolonged ustekinumab treatment in a patient with Crohn's disease and paradoxical psoriasis","volume":"30","author":"Galli-Novak","year":"2016","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0094","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000380880","article-title":"Pregnancy during Ustekinumab Treatment for Severe Psoriasis","volume":"231","author":"Da Rocha","year":"2015","journal-title":"Dermatology"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3315\/jdcr.2012.1116","article-title":"Spontaneous abortion during ustekinumab therapy","volume":"6","author":"Fotiadou","year":"2012","journal-title":"J Dermatol Case Rep"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dth.12895","article-title":"Biologics exposure during pregnancy and breastfeeding in a psoriasis patient","volume":"32","author":"Mugheddu","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0097","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/09546634.2018.1508818","article-title":"Letter to the editor submitted in response to \u201cpsoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab","volume":"30","author":"Megna","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0098","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ecco-jcc\/jjy153","article-title":"Drug Levels in the Maternal Serum, Cord Blood and Breast Milk of a Ustekinumab-Treated Patient with Crohn's Disease. J Crohn's","volume":"13","author":"Klenske","year":"2019","journal-title":"Colitis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0099","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ad.2016.09.004","article-title":"A Case Series of Patients With Psoriasis Exposed to Biologic Therapy During Pregnancy: The BIOBADADERM Register and a Review of the Literature","volume":"108","author":"Echeverr\u00eda-Garc\u00eda","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/09546634.2018.1468066","article-title":"Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab","volume":"30","author":"Galluzzo","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bjd.17086","article-title":"Ustekinumab exposure during conception and pregnancy in patients with chronic plaque psoriasis: a case series of 10 pregnancies","volume":"180","author":"Watson","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0102","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2018.05.040","article-title":"Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development","volume":"155","author":"Matro","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0103","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0104","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/ajd.12214","article-title":"Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester","volume":"55","author":"Sheeran","year":"2014","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dth.12454","article-title":"Use of TNF-inhibitors and ustekinumab for psoriasis during pregnancy: A patient series","volume":"30","author":"Lund","year":"2017","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0106","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3899\/jrheum.171218","article-title":"The effect of pregnancy on disease activity in patients with psoriatic arthritis","volume":"45","author":"Berman","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0107","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1111\/jdv.15671","article-title":"Psoriasis and pregnancy outcomes in biological therapies: a real-life, multi-centre experience","volume":"33","author":"Odorici","year":"2019","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0108","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10875-017-0389-3","article-title":"Placental Transfer of Canakinumab in a Patient with Muckle-Wells Syndrome","volume":"37","author":"Egawa","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0109","first-page":"2102","article-title":"International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors","volume":"56","author":"Youngstein","year":"2017","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0110","first-page":"1692","article-title":"Abatacept concentrations in maternal serum and breast milk during breastfeeding and an infant safety assessment: A case study","volume":"58","author":"Saito","year":"2019","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0111","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2015.06.016","article-title":"Pregnancy outcomes following exposure to abatacept during pregnancy","volume":"45","author":"Kumar","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0112","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2340\/00015555-2923","article-title":"Effect of maternal psoriasis on pregnancy and birth outcomes: A population-based cohort study from Denmark and Sweden","volume":"98","author":"Br\u00f6ms","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0113","first-page":"623","article-title":"Anakinra for myocarditis in juvenile idiopathic arthritis","volume":"40","author":"Movva","year":"2013","journal-title":"Texas Hear Inst J"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0114","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/ard.2008.105833","article-title":"A patient's wish: anakinra in pregnancy","volume":"68","author":"Berger","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1751143718809678","article-title":"Pregnancy-induced haemophagocytic lymphohistiocytosis","volume":"21","author":"Yip","year":"2020","journal-title":"J Intensive Care Soc"},{"issue":"Supplement_3","key":"10.1016\/j.semarthrit.2021.09.004_bib0116","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/rheumatology\/kez108.031","article-title":"A case of pyrexia of unknown origin during pregnancy","volume":"58","author":"Ali","year":"2019","journal-title":"Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0117","first-page":"1271","article-title":"Five successful pregnancies with antenatal anakinra exposure","volume":"57","author":"Smith","year":"2018","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0118","first-page":"1021","article-title":"Successful outcome of two pregnancies in patients with adult-onset Still's disease treated with IL-1 receptor antagonist (anakinra)","volume":"29","author":"Fischer-Betz","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1546-0096-13-S1-P124","article-title":"How safe it is to treat pregnant FMF patients with Anakinra?","volume":"13","author":"Ozdogan","year":"2015","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0120","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1002\/art.38811","article-title":"Brief report: Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes","volume":"66","author":"Chang","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0121","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40264-016-0431-z","article-title":"Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis","volume":"39","author":"Clowse","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0122","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/ibd\/izy160","article-title":"Outcomes of pregnancies with maternal\/paternal exposure in the tofacitinib safety databases for ulcerative colitis","volume":"24","author":"Mahadevan","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X19899296","article-title":"Baricitinib exposure during pregnancy in rheumatoid arthritis","volume":"12","author":"Costanzo","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0124","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/ibd\/izy160","article-title":"Outcomes of pregnancies with maternal\/paternal exposure in the tofacitinib safety databases for ulcerative colitis","volume":"24","author":"Mahadevan","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0125","doi-asserted-by":"crossref","first-page":"e00162","DOI":"10.1016\/j.crwh.2019.e00162","article-title":"Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study","volume":"25","author":"Caniba\u00f1o","year":"2020","journal-title":"Case Reports Women's Heal"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/bfm.2020.0068","article-title":"Belimumab Concentrations in Maternal Serum and Breast Milk during Breastfeeding and the Safety Assessment of the Infant: A Case Study","volume":"15","author":"Saito","year":"2020","journal-title":"Breastfeed Med"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0127","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12687-018-0384-2","article-title":"Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide","volume":"9","author":"Moorthie","year":"2018","journal-title":"J Community Genet"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0128","first-page":"2120","article-title":"Trends in the incidence, rate and treatment of miscarriage - Nationwide register-study in Finland, 1998-2016","volume":"34","author":"Linnakaari","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0129","first-page":"1808","article-title":"Maternal and neonatal outcomes associated with biologic exposure before and during pregnancy in women with inflammatory systemic diseases: A systematic review and meta-analysis of observational studies","volume":"59","author":"Tsao","year":"2020","journal-title":"Rheumatol (United Kingdom)"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0130","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s40265-020-01376-y","article-title":"Intrauterine Exposure to Biologics in Inflammatory Autoimmune Diseases: A Systematic Review","volume":"80","author":"Ghalandari","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0131","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.semarthrit.2018.01.006","article-title":"Paternal exposure to antirheumatic drugs\u2014What physicians should know: Review of the literature","volume":"48","author":"Micu","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0132","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2016.11.004","article-title":"Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-\u03b1 use in females with immune mediated diseases; a systematic review and meta-analysis","volume":"76","author":"Komaki","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2021.09.004_bib0133","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jcpt.12492","article-title":"Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature","volume":"42","author":"Cortes","year":"2017","journal-title":"J Clin Pharm Ther"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017221001827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T08:27:43Z","timestamp":1708763263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017221001827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0049017221001827"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.09.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2021.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}